Czesław Osuch

1.4k total citations
27 papers, 1.0k citations indexed

About

Czesław Osuch is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Czesław Osuch has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Gastroenterology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Czesław Osuch's work include Gastrointestinal Tumor Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastrointestinal disorders and treatments (8 papers). Czesław Osuch is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (9 papers) and Gastrointestinal disorders and treatments (8 papers). Czesław Osuch collaborates with scholars based in Poland, Belgium and United States. Czesław Osuch's co-authors include Piotr Rutkowski, Jerzy Lasota, Zeng-Feng Wang, Agnieszka Woźniak, Maarit Sarlomo‐Rikala, Markku Miettinen, Janusz Limon, Zbigniew Nowecki, Janusz A. Siedlecki and Elżbieta Bylina and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The American Journal of Surgical Pathology.

In The Last Decade

Czesław Osuch

27 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Czesław Osuch Poland 12 744 694 509 210 150 27 1.0k
Oddvar M. Sandvik Norway 8 518 0.7× 460 0.7× 389 0.8× 101 0.5× 192 1.3× 10 784
Michelle Brown Canada 7 669 0.9× 615 0.9× 323 0.6× 141 0.7× 113 0.8× 9 883
Per Bümming Sweden 9 1.3k 1.8× 1.2k 1.7× 868 1.7× 234 1.1× 75 0.5× 13 1.5k
Christine M. Barnett United States 5 523 0.7× 521 0.8× 242 0.5× 107 0.5× 83 0.6× 8 730
Chie‐Schin Shih United States 14 181 0.2× 525 0.8× 276 0.5× 152 0.7× 454 3.0× 33 913
Kevin Raymond United States 12 208 0.3× 711 1.0× 266 0.5× 83 0.4× 299 2.0× 15 875
M. M. Van Glabbeke Netherlands 5 288 0.4× 480 0.7× 175 0.3× 79 0.4× 202 1.3× 8 573
Jochen Schuette Germany 7 260 0.3× 317 0.5× 155 0.3× 73 0.3× 91 0.6× 12 459
R. Bracci Italy 16 225 0.3× 350 0.5× 184 0.4× 49 0.2× 337 2.2× 42 768
Jacek Sygut Poland 13 136 0.2× 175 0.3× 200 0.4× 48 0.2× 142 0.9× 45 496

Countries citing papers authored by Czesław Osuch

Since Specialization
Citations

This map shows the geographic impact of Czesław Osuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Czesław Osuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Czesław Osuch more than expected).

Fields of papers citing papers by Czesław Osuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Czesław Osuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Czesław Osuch. The network helps show where Czesław Osuch may publish in the future.

Co-authorship network of co-authors of Czesław Osuch

This figure shows the co-authorship network connecting the top 25 collaborators of Czesław Osuch. A scholar is included among the top collaborators of Czesław Osuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Czesław Osuch. Czesław Osuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutkowski, Piotr, Marcin Ziętek, Bożena Cybulska-Stopa, et al.. (2020). The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice. European Journal of Surgical Oncology. 47(5). 1191–1195. 12 indexed citations
2.
Sobczuk, Paweł, Paweł Teterycz, Iwona Ługowska, et al.. (2019). Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure. Oncology Letters. 18(3). 3373–3380. 4 indexed citations
3.
Rutkowski, Piotr, Elżbieta Bylina, Iwona Ługowska, et al.. (2018). Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST). Journal of Geriatric Oncology. 9(5). 520–525. 10 indexed citations
4.
Wasąg, Bartosz, Agnieszka Woźniak, Joanna Pikiel, et al.. (2017). Influence of Cytochrome P450, ABC and SLC Gene Polymorphisms on Imatinib Therapy Outcome of Patients with Gastrointestinal Stromal Tumours (GIST). Folia Biologica. 63(2). 78–83. 3 indexed citations
5.
Cieniawski, Dominik, et al.. (2017). Beneficial effect of kidney transplantation from a deceased donor on severe chronic refractory intradialytic hypotension – a case report. BMC Nephrology. 18(1). 248–248. 5 indexed citations
6.
Osuch, Czesław, et al.. (2014). The Outcome of Targeted Therapy in Advanced Gastrointestinal Stromal Tumors (Gist) with Non-Exon 11 Kit Mutations. Polish Journal of Surgery. 86(7). 325–32. 2 indexed citations
7.
Rutkowski, Piotr, Elżbieta Bylina, Czesław Osuch, et al.. (2013). What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?. Medical Oncology. 30(4). 765–765. 24 indexed citations
8.
Sowa‐Staszczak, Anna, Dorota Pach, Renata Mikołajczak, et al.. (2012). Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. European Journal of Nuclear Medicine and Molecular Imaging. 40(4). 524–531. 90 indexed citations
9.
Rutkowski, Piotr, Elżbieta Bylina, Anna Klimczak, et al.. (2012). The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC Cancer. 12(1). 107–107. 62 indexed citations
10.
Woźniak, Agnieszka, Piotr Rutkowski, A Piskorz, et al.. (2011). Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience. Annals of Oncology. 23(2). 353–360. 116 indexed citations
11.
Rutkowski, Piotr, Elżbieta Bylina, Agnieszka Woźniak, et al.. (2011). Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes. European Journal of Surgical Oncology. 37(10). 890–896. 127 indexed citations
12.
Miettinen, Markku, Zeng-Feng Wang, Maarit Sarlomo‐Rikala, et al.. (2011). Succinate Dehydrogenase-Deficient GISTs. The American Journal of Surgical Pathology. 35(11). 1712–1721. 246 indexed citations
13.
Okoń, Krzysztof, et al.. (2010). BRAF mutations in sporadic colorectal carcinoma from polish patients.. PubMed. 61(1). 23–6. 13 indexed citations
14.
Rutkowski, Piotr, Jan Kulig, Czesław Osuch, et al.. (2008). Zasady postępowania diagnostyczno-terapeutycznego u chorych na nowotwory podścieliskowe przewodu pokarmowego (GIST) w 2008 roku. Nowotwory Journal of Oncology. 58(6). 537–537. 1 indexed citations
15.
Dêbiec‐Rychter, Maria, Piotr Rutkowski, Peter Reichardt, et al.. (2007). Aktualne postępowanie diagnostyczno-terapeutyczne u chorych na nowotwory podścieliskowe przewodu pokarmowego (GIST). Nowotwory Journal of Oncology. 57(2). 181–181. 1 indexed citations
16.
Rutkowski, Piotr, Zbigniew Nowecki, Wanda Michej, et al.. (2007). Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor. Annals of Surgical Oncology. 14(7). 2018–2027. 207 indexed citations
17.
Rutkowski, Piotr, Zbigniew Nowecki, Maria Dȩbiec‐Rychter, et al.. (2007). Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs). Journal of Cancer Research and Clinical Oncology. 133(9). 589–597. 29 indexed citations
18.
19.
Okoń, Krzysztof, et al.. (2006). Correlation of microsatellite status, proliferation, apoptotic and selected immunohistochemical markers in colorectal carcinoma studied with tissue microarray.. PubMed. 57(2). 105–11. 2 indexed citations
20.
Okoń, Krzysztof, et al.. (2004). CDX-2 expression is reduced in colorectal carcinomas with solid growth pattern and proximal location, but is largely independent of MSI status.. PubMed. 55(3). 9–14. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oddvar M. Sandvik Breakdown of academic impact, for papers by Michelle Brown Breakdown of academic impact, for papers by Per Bümming Breakdown of academic impact, for papers by Christine M. Barnett Breakdown of academic impact, for papers by Chie‐Schin Shih Breakdown of academic impact, for papers by Kevin Raymond Breakdown of academic impact, for papers by M. M. Van Glabbeke Breakdown of academic impact, for papers by Jochen Schuette Breakdown of academic impact, for papers by R. Bracci Breakdown of academic impact, for papers by Jacek Sygut
Rankless by CCL
2026